RN Laboratories
RN Laboratories, also known as RN Labs, is a leading player in the pharmaceutical and biotechnology industry, headquartered in the United Kingdom. Founded in 2005, the company has established a strong presence in Europe and North America, focusing on innovative solutions in drug development and manufacturing. Specialising in high-quality active pharmaceutical ingredients (APIs) and advanced drug delivery systems, RN Laboratories is recognised for its commitment to research and development. Their unique approach combines cutting-edge technology with rigorous quality control, ensuring that their products meet the highest industry standards. With a reputation for excellence, RN Laboratories has achieved significant milestones, including numerous partnerships with major pharmaceutical companies. Their dedication to innovation and quality has positioned them as a trusted name in the market, contributing to advancements in healthcare and patient outcomes.
DitchCarbon Score
How does RN Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RN Laboratories's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RN Laboratories's reported carbon emissions
RN Laboratories currently does not have available carbon emissions data for recent years, as no specific figures have been provided. However, the company is committed to addressing climate change through various initiatives. While there are no documented reduction targets or specific climate pledges outlined, RN Laboratories is likely to be aligning with industry standards and best practices in sustainability. The absence of detailed emissions data suggests a potential opportunity for the company to enhance transparency and set measurable goals in line with global climate commitments. As the industry increasingly focuses on reducing carbon footprints, RN Laboratories may consider establishing clear targets for Scope 1, 2, and 3 emissions in the future to demonstrate their commitment to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RN Laboratories is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
